SAPA-China 2024 Annual conference

이벤트:

Join Novotech at the SAPA-China 2024 Annual Conference, on October 18-19 at the Suzhou Shishan International Conference Centre. This premier event, themed Enhance Innovative Cooperation & Accelerating Industry Integration, will attract over 7,000 key players from research institutes, pharma, and biotech across China and the U.S.

The conference will focus on the most pressing topics in the industry, including large/small molecule therapies, cell and gene therapy, AI in pharmaceuticals, nucleic acids, peptides, clinical trials, radiopharmaceuticals, conjugated drugs, and international collaboration. Attendees will have the opportunity to engage in high-level and thematic forums, project collaborations, financing discussions, and exhibitions.

Don’t miss Charley Sha, Head of Regulatory Affairs at Novotech China, as he presents Regulatory Considerations for Early-Phase Clinical Trials in Australia on October 18, 15:05-15:30, at the Global Registration and Regulatory Affairs Forum.

This is a prime opportunity to connect, collaborate, and stay ahead in the rapidly evolving pharmaceutical landscape. Be sure to meet with the Novotech team and catch Charley’s insights to boost your clinical trial success.

We look forward to welcoming you to Suzhou for this prestigious event!